Ting Spray Powder

Manufacturer
Insight Pharmaceuticals LLC
Effective date
2024-10-25
Label type
HUMAN OTC DRUG LABEL
Version
7
Source
legacy-cache
Hydrated at
2026-08-01 20:49:43

Label at a glance#

ProductTing
Active ingredientMICONAZOLE NITRATE
Label structure10 sections

Indications and uses

 ▪ effective in the treatment of most athlete's foot (tinea pedis), jock itch (tinea cruris) and ringworm (tinea corporis) ▪ effectively relieves itching, scaling, burning and discomfort that can accompany athlete's foot and jock itch

Dosage and administration

▪ clean the affected area and dry thoroughly▪ shake can well, hold  4" to 6" from skin. Spray a thin layer of the product over affected area twice daily (morning and night) or as directed by a doctor▪ supervise children in the use of this product. ▪ for athlete's foot, pay special attention to the spaces between the toes; wear well-fitting, ventilated shoes and change shoes and socks at least once daily.▪ for athl...

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Drug Facts

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

Miconazole Nitrate 2%

Purpose

OTC - PURPOSE SECTION

Antifungal

Uses

INDICATIONS & USAGE SECTION

 ▪ effective in the treatment of most athlete's foot (tinea pedis), jock itch (tinea cruris) and ringworm (tinea corporis)

▪ effectively relieves itching, scaling, burning and discomfort that can accompany athlete's foot and jock itch

Warnings

WARNINGS SECTION

For external use onlyFlammability Warning:  Contents under pressure. Do not puncture or incinerate. Flammable mixture; do not use near fire or flame, or expose to heat or temperatures above 49°C (120°F). Use only as directed. Intentional misuse by deliberately concentrating and inhaling contents can be harmful or fatal.

When using this product

OTC - WHEN USING SECTION

avoid contact with the eyes

Do not use

OTC - DO NOT USE SECTION

▪ in or near the mouth or the eyes

▪ for nail or scalp infections

Stop use and ask a doctor if

OTC - STOP USE SECTION

irritation occurs or if there is no improvement within 4 weeks (for athlete's foot and ringworm) or 2 weeks (for jock itch)Do not use on children under 2 years of unless directed by a doctor.

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

Directions

DOSAGE & ADMINISTRATION SECTION

▪ clean the affected area and dry thoroughly▪ shake can well, hold  4" to 6" from skin. Spray a thin layer of the product over affected area twice daily (morning and night) or as directed by a doctor▪ supervise children in the use of this product. ▪ for athlete's foot, pay special attention to the spaces between the toes; wear well-fitting, ventilated shoes and change shoes and socks at least once daily.▪ for athlete's foot and ringworm use daily for 4 weeks; for jock itch, use daily for 2 weeks. If condition persists longer, consult a doctor.

Other information

OTHER SAFETY INFORMATION

Store at room temperature 15°-25°C (59°-77°F).

Inactive ingredients

INACTIVE INGREDIENT SECTION

Aloe vera gel, aluminum starch octenylsuccinate, isopropyl myristate, propylene carbonate, SD alcohol 40-B (10% w/w), sorbitan monooleate, stearalkonium hectorite. Propellant: Isobutane, normal butane, propane

Questions?

OTC - QUESTIONS SECTION

1-800-344-7239©2016  Distributed by INSIGHT Pharmaceuticals Corp., a Prestige Brands Company

Tarrytown, NY 10591Made in India

TAMPER RESISTANT AEROSOL CAN FOR YOUR PROTECTION

Principal display panel:

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Ting ®
Athlete’s Foot Spray

2% Miconazole Nitrate
Antifungal Spray Powder

Net WT 4.5 oz (128 g)

Ting ® Athlete’s Foot Spray 2% Miconazole Nitrate Antifungal Spray Powder Net WT 4.5 oz (128 g)Ting ® Athlete’s Foot Spray 2% Miconazole Nitrate Antifungal Spray Powder Net WT 4.5 oz (128 g)

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
63736-532-052023-03-02C16284748780-19d75b9d0-bb1b-f424-e053-dadaa90a57ceTing Spray Powder
63736-532-052023-01-30C16284748780-19d75b9d0-bb1b-f424-e053-dadaa90a57ceTing Spray Powder
63736-532-052020-04-13C16284748780-19d75b9d0-bb1b-f424-e053-dadaa90a57ceTing Spray Powder
63736-532-052020-01-31C16284748780-19d75b9d0-bb1b-f424-e053-dadaa90a57ceTing Spray Powder

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
Miconazole NitrateACTIVE INGREDIENTVW4H1CYW1K2
MiconazoleACTIVE MOIETY7NNO0D7S5M2
Aloe vera leafINACTIVE INGREDIENTZY81Z83H0X2
IsobutaneINACTIVE INGREDIENTBXR49TP6112
isopropyl myristateINACTIVE INGREDIENT0RE8K4LNJS2
PropaneINACTIVE INGREDIENTT75W9911L62
propylene carbonateINACTIVE INGREDIENT8D08K3S51E2
sorbitan monooleateINACTIVE INGREDIENT06XEA2VD562

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 13 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
63736-53263736-532-05

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 11 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 41 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
sorbitan monooleateSORBITAN MONOOLEATE06XEA2VD56GEL / TOPICAL20 mgExact identifier — unii candidate
16 equally ranked IID candidates
sorbitan monooleateSORBITAN MONOOLEATE06XEA2VD56CREAM / TOPICAL11000 mgExact identifier — unii candidate
16 equally ranked IID candidates
sorbitan monooleateSORBITAN MONOOLEATE06XEA2VD56OINTMENT / TOPICALNAExact identifier — unii candidate
16 equally ranked IID candidates
sorbitan monooleateSORBITAN MONOOLEATE06XEA2VD56EMULSION / TOPICAL34050 mgExact identifier — unii candidate
16 equally ranked IID candidates
sorbitan monooleateSORBITAN MONOOLEATE06XEA2VD56SOLUTION / ORAL1080 mgExact identifier — unii candidate
16 equally ranked IID candidates
isopropyl myristateISOPROPYL MYRISTATE0RE8K4LNJSOIL / AURICULAR (OTIC)36 mgExact identifier — unii candidate
18 equally ranked IID candidates
sorbitan monooleateSORBITAN MONOOLEATE06XEA2VD56TABLET, DELAYED RELEASE / ORAL4 mgExact identifier — unii candidate
16 equally ranked IID candidates
sorbitan monooleateSORBITAN MONOOLEATE06XEA2VD56TABLET, FILM COATED, EXTENDED RELEASE / ORAL2 mgExact identifier — unii candidate
16 equally ranked IID candidates
isopropyl myristateISOPROPYL MYRISTATE0RE8K4LNJSOINTMENT / TOPICAL35 %w/wExact identifier — unii candidate
18 equally ranked IID candidates
IsobutaneISOBUTANEBXR49TP611AEROSOL, SPRAY / TOPICAL4484 mgExact identifier — unii candidate
4 equally ranked IID candidates
isopropyl myristateISOPROPYL MYRISTATE0RE8K4LNJSCREAM / TOPICAL65000 mgExact identifier — unii candidate
18 equally ranked IID candidates
isopropyl myristateISOPROPYL MYRISTATE0RE8K4LNJSGEL / TRANSDERMAL85 mgExact identifier — unii candidate
18 equally ranked IID candidates
isopropyl myristateISOPROPYL MYRISTATE0RE8K4LNJSSUSPENSION / AURICULAR (OTIC)0.02 %w/wExact identifier — unii candidate
18 equally ranked IID candidates
IsobutaneISOBUTANEBXR49TP611AEROSOL, FOAM / RECTAL142 mgExact identifier — unii candidate
4 equally ranked IID candidates
isopropyl myristateISOPROPYL MYRISTATE0RE8K4LNJSLOTION / TOPICAL50 mgExact identifier — unii candidate
18 equally ranked IID candidates
isopropyl myristateISOPROPYL MYRISTATE0RE8K4LNJSSYSTEM / TOPICAL7 mgExact identifier — unii candidate
18 equally ranked IID candidates
IsobutaneISOBUTANEBXR49TP611AEROSOL / TOPICAL4484 mgExact identifier — unii candidate
4 equally ranked IID candidates
sorbitan monooleateSORBITAN MONOOLEATE06XEA2VD56TABLET / ORAL19 mgExact identifier — unii candidate
16 equally ranked IID candidates
isopropyl myristateISOPROPYL MYRISTATE0RE8K4LNJSSPRAY / TOPICAL3665 mgExact identifier — unii candidate
18 equally ranked IID candidates
sorbitan monooleateSORBITAN MONOOLEATE06XEA2VD56CAPSULE / ORAL288 mgExact identifier — unii candidate
16 equally ranked IID candidates
propylene carbonatePROPYLENE CARBONATE8D08K3S51EOINTMENT / TOPICAL3000 mgExact identifier — unii candidate
isopropyl myristateISOPROPYL MYRISTATE0RE8K4LNJSAEROSOL, SPRAY / TOPICAL6.89 %w/wExact identifier — unii candidate
18 equally ranked IID candidates
PropanePROPANET75W9911L6AEROSOL, FOAM / TOPICAL55 %w/wExact identifier — unii candidate
2 equally ranked IID candidates
IsobutaneISOBUTANEBXR49TP611AEROSOL, FOAM / TOPICAL18 %w/wExact identifier — unii candidate
4 equally ranked IID candidates
isopropyl myristateISOPROPYL MYRISTATE0RE8K4LNJSOIL / TOPICAL213 mgExact identifier — unii candidate
18 equally ranked IID candidates
sorbitan monooleateSORBITAN MONOOLEATE06XEA2VD56SUPPOSITORY / RECTAL390 mgExact identifier — unii candidate
16 equally ranked IID candidates
sorbitan monooleateSORBITAN MONOOLEATE06XEA2VD56TABLET, FILM COATED / ORAL12 mgExact identifier — unii candidate
16 equally ranked IID candidates
sorbitan monooleateSORBITAN MONOOLEATE06XEA2VD56FILM, EXTENDED RELEASE / TRANSDERMALNAExact identifier — unii candidate
16 equally ranked IID candidates
PropanePROPANET75W9911L6AEROSOL, FOAM / RECTAL9 mgExact identifier — unii candidate
2 equally ranked IID candidates
isopropyl myristateISOPROPYL MYRISTATE0RE8K4LNJSCREAM / VAGINAL50 mgExact identifier — unii candidate
18 equally ranked IID candidates
isopropyl myristateISOPROPYL MYRISTATE0RE8K4LNJSAEROSOL, FOAM / TOPICAL144 mgExact identifier — unii candidate
18 equally ranked IID candidates
isopropyl myristateISOPROPYL MYRISTATE0RE8K4LNJSFILM, EXTENDED RELEASE / TRANSDERMAL20.4 mgExact identifier — unii candidate
18 equally ranked IID candidates
sorbitan monooleateSORBITAN MONOOLEATE06XEA2VD56SPRAY / TOPICAL8 mgExact identifier — unii candidate
16 equally ranked IID candidates
isopropyl myristateISOPROPYL MYRISTATE0RE8K4LNJSSYSTEM / TRANSDERMAL113 mgExact identifier — unii candidate
18 equally ranked IID candidates
isopropyl myristateISOPROPYL MYRISTATE0RE8K4LNJSGEL, METERED / TRANSDERMAL50 mgExact identifier — unii candidate
18 equally ranked IID candidates
isopropyl myristateISOPROPYL MYRISTATE0RE8K4LNJSAEROSOL / TOPICAL9.3 %w/wExact identifier — unii candidate
18 equally ranked IID candidates
sorbitan monooleateSORBITAN MONOOLEATE06XEA2VD56LOTION / TOPICAL7 mgExact identifier — unii candidate
16 equally ranked IID candidates
isopropyl myristateISOPROPYL MYRISTATE0RE8K4LNJSFILM / TRANSDERMAL58.08 mgExact identifier — unii candidate
18 equally ranked IID candidates
sorbitan monooleateSORBITAN MONOOLEATE06XEA2VD56TABLET, COATED / ORAL0.13 mgExact identifier — unii candidate
16 equally ranked IID candidates
isopropyl myristateISOPROPYL MYRISTATE0RE8K4LNJSGEL / TOPICAL29 mgExact identifier — unii candidate
18 equally ranked IID candidates
sorbitan monooleateSORBITAN MONOOLEATE06XEA2VD56SYSTEM / TRANSDERMAL2.33 mgExact identifier — unii candidate
16 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
04151d72-2d2f-401f-af8e-b85f93bfda9efb58c46f-d405-4b45-b947-39f177624df52024-10-25WarningsExact identifier
spl id: 04151d72-2d2f-401f-af8e-b85f93bfda9e
spl set id: fb58c46f-d405-4b45-b947-39f177624df5

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.